NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NASDAQ · Medical Instruments & Supplies · USD

Azenta, Inc. (AZTA) Stock Analysis

Azenta, Inc. (AZTA) is a Medical Instruments & Supplies stock listed on NASDAQ and quoted in US Dollar.

AZTA

$31.33

+$0.15 (+0.48%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare AZTA with… →

AZTA Key Statistics

As of Sep 4, 2026
Trading
Open
$30.66
Previous Close
$31.18
Day's Range
30.61–31.58
52-Week Range
15.93–41.73
Volume
751.90K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
1.39
Valuation
Market Cap
$1.37B
P/E Ratio
unprofitable
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
53.33
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
0.53
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
2.24
EPS (ttm)Profit attributable to each share over the last twelve months.
−2.47
Financials (FY)
Revenue (FY)
$593.82M+3.55%
Net Income (FY)
−$55.76M
Profit marginThe share of revenue left as profit after all costs and taxes.
−20.02%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
43.81M
1-Year Return
+6.13%
Dividend and dates
Earnings Date
November 20, 2026estimated
Avg Volume
720.64K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

AZTA Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−5.80%
2025−33.48%
2024−23.24%
2023+11.89%
2022−43.54%
2021+52.62%
2020+63.07%
2019+62.06%
2018+11.20%
2017+42.03%
2016 (partial year)+38.14%

As of September 4, 2026.

AZTA Revenue and Earnings by Fiscal Year

FY ends September
Fiscal yearRevenueNet incomeNet margin
2025$593.82M−$55.76M−9.4%
2024$573.45M−$164.90M−28.8%
2023$551.49M−$14.64M−2.7%
2022$555.50M$2.13B384.0%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$593.82M$270.28M−$21.67M−$55.76M−9.4%
2024$573.45M$254.62M−$39.86M−$164.90M−28.8%
2023$551.49M$239.21M−$56.67M−$14.64M−2.7%
2022$555.50M$255.58M−$23.42M$2.13B384.0%

Annual figures as reported, in the company's reporting currency. As of September 30, 2025.

AZTA Valuation vs Medical Instruments & Supplies Median

Median of 55 stocks
MetricAZTAMedical Instruments & Supplies medianvs median
P/S ratio2.243.1730% below
Profit margin−20.02%0.85%20.9 pts below

Medians across 55 Medical Instruments & Supplies stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

All 8 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Azenta, Inc. (AZTA) is capitalised at $1.37B on the latest close. The company sits in the Healthcare sector, in the Medical Instruments & Supplies industry. Headcount on file is 2,900.

The 52-week range on file runs from $15.93 to $41.73. The most recent close on file for AZTA is $31.33, dated September 4, 2026. That is +$0.15 (+0.48%) against the previous close. The latest close sits 96.67% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $593.82M. Against the prior fiscal year total of $573.45M, that is a change of +3.55%. The same year closed with a net loss of $55.76M. The reported profit margin is −20.02%. That is 20.9 percentage points below the Medical Instruments & Supplies median of 0.85%. Earnings per share on a trailing basis come to −2.47.

Across the 4 fiscal years on file, revenue moves from $555.50M in 2022 to $593.82M in 2025. Of those 4 years, 1 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. On forward earnings the ratio is 53.33. The PEG ratio, which sets the P/E against expected earnings growth, reads 0.53. Measured against sales, the shares trade at 2.24 times revenue. On price-to-sales that is 29.52% below the Medical Instruments & Supplies median of 3.17. 55 Medical Instruments & Supplies companies report these metrics, and the medians quoted come from that group.

The trailing one-year price return is +6.13%. Across 10 years the annualized return works out at +10.00%. Beta against the wider market is reported at 1.39. Annualized volatility over the trailing 10 years is 51.9%.

Growth & Income

No dividend is on file for AZTA.

Across the complete calendar years on file, 2020 returned +63.07% and 2022 returned −43.54%. Of the 9 complete calendar years on file, 6 finished higher. 2026 is still running; the price is −5.80% year to date.

Peer Comparison

Azenta, Inc. (AZTA) operates in the Medical Instruments & Supplies industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Azenta, Inc. AZTA $1.37B —
Intuitive Surgical, Inc. ISRG $131.38B 42.4
Becton, Dickinson and Company BDX $50.32B 32.0
Medline Inc. MDLN $49.23B 45.7

The Medical Instruments & Supplies industry average P/E ratio is 35.6x. Azenta, Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Instruments & Supplies Stocks

ISRG

Intuitive Surgical, Inc.

$131.38B

 BDX

Becton, Dickinson and Company

$50.32B

 MDLN

Medline Inc.

$49.23B

 ALC

Alcon Inc.

$34.08B

 RMD

ResMed Inc.

$32.94B

 WST

West Pharmaceutical Services, Inc.

$23.93B
View all Medical Instruments & Supplies stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About Azenta, Inc.

Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences industry in the United States, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. It operates through Sample Management Solutions and Multiomics segments. The Sample Management Solutions segment provides sample management products and services, including automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled rate thawing devices, as well as sample repository services. This segment also offers consultation services to clients throughout their experimental design and implementation processes. The Multiomics segment provides genomic and other sample analysis services comprising gene sequencing, gene synthesis, and related services. The company has a strategic partnership with Frontier Space Ltd to conduct scientific experiments in space. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.

Visit website →